Proliferation of NS0 cells in protein-free medium: The role of cell-derived proteins, known growth factors and cellular receptors

Journal of Biotechnology

Volumn 141, Issue 3-4, 2009, Pages 123-129

  Spens, Erika ^a   Häggström, Lena ^a  

^a ROYAL INSTITUTE OF TECHNOLOGY   (Sweden)

Author keywords

Autocrine growth factors; Conditioned medium; gp130; NS0 myeloma cells; Regulation of proliferation

Indexed keywords

AUTOCRINE GROWTH FACTORS; CONDITIONED MEDIUM; GP130; NS0 MYELOMA CELLS; REGULATION OF PROLIFERATION;

BIOACTIVITY; CELL DEATH; CELL GROWTH; CELL PROLIFERATION; COMPUTER SOFTWARE MAINTENANCE; GENETIC ENGINEERING; GROWTH KINETICS; PEPTIDES; SIGNAL TRANSDUCTION; TUMORS;

CELL MEMBRANES;

ALPHA INTERFERON; BETA 2 MICROGLOBULIN; BETA INTERFERON; CELL PROTEIN; COMPLEMENTARY DNA; CYCLOPHILIN A; CYCLOPHILIN B; CYSTATIN C; DOPACHROME TAUTOMERASE; EPIDERMAL GROWTH FACTOR; GAMMA INTERFERON; GAMMA INTERFERON RECEPTOR; GLYCOPROTEIN GP 130; INTERLEUKIN 11; INTERLEUKIN 25; INTERLEUKIN 6; ISOPENTENYL DIPHOSPHATE DELTA ISOMERASE; LEUKEMIA INHIBITORY FACTOR; MACROPHAGE MIGRATION INHIBITION FACTOR; ONCOSTATIN M; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR; SMALL INTERFERING RNA; SOMATOMEDIN B; SOMATOMEDIN C; THIOREDOXIN 1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA; TUMOR PROTEIN; UBIQUITIN;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CELL DEATH; CELL GROWTH; CELL MEMBRANE; CELL PROLIFERATION; CONTROLLED STUDY; CULTURE MEDIUM; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENE SILENCING; GENETIC TRANSCRIPTION; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; SIGNAL TRANSDUCTION;

ANIMALS; CELL LINE, TUMOR; CELL PROLIFERATION; CULTURE MEDIA, CONDITIONED; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; RECEPTORS, CELL SURFACE; RNA, SMALL INTERFERING; SEQUENCE ANALYSIS, PROTEIN;

ANIMALIA;

EID: 67349229594     PISSN: 01681656     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jbiotec.2008.04.015     Document Type: Article

References (39)

1. Amoroso S.R., Huang N., Roberts A.B., Potter M., and Letterio J.J. Consistent loss of functional transforming growth factor b receptor expression in murine plasmacytomas. Proc. Natl. Acad. Sci. U.S.A. 95 (1998) 189-194
2. Berenson J.R., Sjak-Shie N.N., and Vescio R.A. The role of human and viral cytokines in the pathogenesis of multiple myeloma. Semin. Cancer Biol. 10 (2000) 383-391
3. Bukrinsky M.I. Cyclophilins: unexpected messengers in intercellular communications. Trends Immunol. 23 (2002) 323-325
4. Child J.A., and Kushwaha M.R. Serum beta 2-microglobulin in lymphoproliferative and myeloproliferative diseases. Hematol. Oncol. 2 (1984) 391-401
5. Daino H., Matsumura I., Takada K., Odajima J., Tanaka H., Ueda S., Shibayama H., Ikeda H., Hibi M., Machii T., Hirano T., and Kanakura Y. Induction of apoptosis by extracellular ubiquitin in human hematopoietic cells: possible involvement of STAT3 degradation by proteasome pathway in interleukin 6-dependent hematopoietic cells. Blood 95 (2000) 2577-2585
6. Eriksson U., Hassel J., Lüllau E., and Häggström L. Metalloproteinase activity is the sole factor responsible for the growth-promoting effect of conditioned medium in Trichoplusia ni insect cell cultures. J. Biotechnol. 119 (2005) 76-86
7. Ernst M., and Jenkins B.J. Acquiring signaling specificity from the cytokine receptor gp130. Trends Genet. 20 (2004) 23-32
8. Ferlin M., Noraz N., Hertogh C., Brochier J., Taylor N., and Klein B. Insulin-like growth factor induces the survival and proliferation of myeloma cells through an interleukin-6-independent transduction pathway. Br. J. Haematol. 111 (2000) 626-634
9. French J.D., Walters D.K., and Jelinek D.F. Transactivation of gp130 in myeloma cells. J. Immunol. 170 (2003) 3717-3723
10. Gu Z.-J., De Vos J., Rebouissou C., Jourdan M., Zhang X.-G., Rossi J.-F., Wijdenes J., and Klein B. Agonist anti-gp130 transducer monoclonal antibodies are human myeloma cell survival and growth factors. Leukemia 14 (2000) 188-197
11. Kallen K.-J. The role of transsignalling via the agonistic soluble IL-6 receptor in human diseases. BBA: Mol. Cell Res. 1592 (2002) 323-343
12. Kang H.S., Lee M.J., Song H.H., Seung H., Kim Y.M., Im J.Y., and Choi I. Molecular identification of IgE-dependent histamine-releasing factor as a B cell growth factor. J. Immunol. 166 (2001) 6545-6554
13. Kawaguchi M., Adachi M., Oda N., Kokubu F., and Huang S.-K. IL-17 cytokine family. J. Allergy Clin. Immun. 114 (2004) 1265-1273
14. Klein B., Tarte K., Jourdan M., Mathouk K., Moreaux J., Jourdan E., Legouffe E., De Vos J., and Rossi J.F. Survival and proliferation factors of normal and malignant plasma cells. Int. J. Hematol. 78 (2003) 106-113
15. Ko D.C., Binkley J., Sidow A., and Scott M.P. The integrity of a cholesterol-binding pocket in Niemann-Pick C2 protein is necessary to control lysosome cholesterol levels. Proc. Natl. Acad. Sci. U.S.A. 100 (2003) 2518-2525
16. Lattanzio G., Libert C., Aquilina M., Cappelletti M., Ciliberto G., Musiani P., and Poli V. Defective development of pristane-oil-induced plasmacytomas in interleukin-6-deficient BALB/c mice. Am. J. Pathol. 151 (1997) 689-696
17. Le J., Reis L.F.L., and Vilcek J. Tumor necrosis factor and interleukin 1 can act as essential growth factors in a murine plasmacytoma line. Lymphokine Res. 7 (1988) 99-106
18. Lindskog, E., 2006. Physiology and productivity of serum-free Spodoptera frugiperda Sf9 insect cell cultures. PhD Thesis, Royal Institute of Technology (KTH), Stockholm, Sweden.
19. Mitchell R.A., and Bucala R. Tumor growth-promoting properties of macrophage migration inhibitory factor (MIF). Semin. Cancer Biol. 10 (2000) 359-366
20. Mitsiades C.S., Mitsiades N., Poulaki V., Schlossman R., Akiyama M., Chauhan D., Hideshima T., Treon S.P., Munshi N.C., Richardson P.G., and Anderson K.C. Activation of NF-kB and upregulation of intracellular anti-apoptotic proteins via the IGF-1/Akt signaling in human multiple myeloma cells: therapeutic implications. Oncogene 21 (2002) 5673-5683
21. Narazaki M., Yasukawa K., Saito T., Ohsugi Y., Fukui H., Koishihara Y., Yancopoulos G.D., Taga T., and Kishimoto T. Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130. Blood 82 (1993) 1120-1126
22. Nishihira J., Sugimoto H., and Tanaka I. Overview of biological functions of macrophage migration inhibitory factor and D-dopachrome tautomerase based on the gene and protein structures. Curr. Top. Biochem. Res. 1 (1999) 59-73
23. Podar K., Hideshima T., Chauhan D., and Anderson K.C. Targeting signalling pathways for the treatment of multiple myeloma. Expert. Opin. Ther. Target. 9 (2005) 359-381
24. Potter M. Perspectives on the origins of multiple myeloma and plasmacytomas in mice. Hematol. Oncol. Clin. N. Am. 6 (1992) 211-223
25. Potter M., and Wiener F. Plasmacytomagenesis in mice: model of neoplastic development dependent upon chromosomal translocations. Carcinogenesis 13 (1992) 1681-1697
26. Powis G., Mustacich D., and Coon A. The role of the redox protein thioredoxin in cell growth and cancer. Free Radical Biol. Med. 29 (2000) 312-322
27. Pratt G. Molecular aspects of multiple myeloma. Mol. Pathol. 55 (2002) 273-283
28. Sambrook J., Fritsch E.F., and Maniatis T. Molecular Cloning (1989), Cold Spring Harbor Laboratory, New York
29. Seidl S., Kaufmann H., and Drach J. New insights into the pathophysiology of multiple myeloma. Lancet Oncol. 4 (2003) 557-564
30. Seth G., McIvor R.S., and Hu W.-S. 17β-Hydroxysteroid dehydrogenase type 7 (Hsd17b7) reverts cholesterol auxotrophy in NS0 cells. J. Biotechnol. 121 (2006) 241-252
31. Sonesson B., Rosengren E., Hansson A.-S., and Hansson C. UVB-induced inflammation gives increased D-dopachrome tautomerase activity in blister fluid which correlates with macrophage migration inhibitory factor. Exp. Dermatol. 12 (2003) 278-282
32. Spens E., and Häggström L. Defined protein-free NS0 myeloma cell cultures: stimulation of proliferation by conditioned medium factors. Biotechnol. Progr. 21 (2005) 87-95
33. Spens E., and Häggström L. Protease activity in protein-free NS0 myeloma cell cultures. In Vitro Cell. Dev. Biol.: Animal 41 (2005) 330-336
34. Spens E., and Häggström L. Defined protein and animal component-free NS0 fed-batch culture. Biotechnol. Bioeng. 98 (2007) 1183-1194
35. Urashima M., Ogata A., Chauhan D., Hatziyanni M., Vidriales M.B., Dedera D.A., Schlossman R.L., and Anderson K.C. Transforming growth factor-b1: differential effects on multiple myeloma versus normal B cells. Blood 87 (1996) 1928-1938
36. Wang Y.D., De Vos J., Jourdan M., Couderc G., Lu Z.-Y., Rossi J.-F., and Klein B. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells. Oncogene 21 (2002) 2584-2592
37. Watanabe-Fukunaga R., Brannan C.I., Itoh N., Yonehara S., Copeland N.G., Jenkins N.A., and Nagata S. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148 (1992) 1274-1279
38. Yasui H., Hideshima T., Richardson P.G., and Anderson K.C. Novel therapeutic strategies targeting growth factor signalling cascades in multiple myeloma. Br. J. Haematol. 132 (2006) 385-397
39. Yurchenko V., O'Connor M., Dai W.W., Guo H., Toole B., Sherry B., and Bukrinsky M. CD147 is a signaling receptor for cyclophilin B. Biochem. Biophys. Res. Co. 288 (2001) 786-788